FrancophonIA/ELRC3.0 huggingface dataset:
English: For Targocid, powder and solvent for solution for injection/infusion or oral solution - 1 powder vial with 1 solvent ampoule - 5x1 powder vials with 5x1 solvent ampoules - 10x1 powder vials with 10x1 solvent ampoules - 25x1 powder vials with 25x1 solvent ampoules
Danish: For Targocid, pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning - 1 hætteglas med pulver samt 1 ampul med solvens - 5x1hætteglas med pulver samt 5x1 ampuller med solvens - 10x1 hætteglas med pulver samt 10x1 ampuller med solvens - 25x1 hætteglas med pulver samt 25x1 ampuller med solvens
English: Anaphylactic reaction (anaphylaxis) (see section 4.4)
Danish: Anafylaktisk reaktion (anafylaksi) (se pkt.
English: Teicoplanin is not removed by haemodialysis.
Danish: Teicoplanin fjernes ikke ved hæmodialyse.
English: After a loading dose of 6 mg/kg administered intravenously every 12 hours for 3 to 5 administrations, Cmax values range from 60 to 70 mg/L and Ctrough are usually above 10 mg/L.
Danish: Efter en startdosis på 6 mg/kg intravenøst hver 12. time givet 3-5 gange spænder Cmax-værdien fra 60 til 70 mg/l, og Cmin er normalt over 10 mg/l.
English: • Ringer-lactate solution
Danish: • Ringer-laktat opløsning
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Danish: NAVN OG ADRESSE PÅ INDEHAVER AF MARKEDSFØRINGSTILLADELSEN [Se bilag I - Udfyldes nationalt]
English: • Week one: 20 mg/L in each dialysis bag
Danish: • Uge 1: 20 mg/l i hver dialysepose
English: Ringer-lactate solution
Danish: Ringer-lactat-injektionsvæske
English: Rare (≥1/10,000 to
Danish: Sjælden til <1/1.000)
English: Shelf life of diluted medicinal product:
Danish: Holdbarhed for det fortyndede lægemiddel:
English: 6 mg/kg body weight intravenous or intramuscular once a day
Danish: 6 mg/kg legemsvægt intravenøst eller intramuskulært én gang dagligt
English: After a maintenance dose of 6 mg/kg administered once daily Cmax and Ctrough values are approximately 70 mg/L and 15 mg/L, respectively.
Danish: Efter en vedligeholdelsesdosis på 6 mg/kg indgivet én gang dagligt er Cmax og Cmin hhv. ca. 70 mg/l og 15 mg/l.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON FOR 100 mg, 200 mg and 400 mg / powder for solution for injection/infusion or oral solution
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON TIL 100 mg, 200 mg og 400 mg/pulver til injektions-/infusionsvæske, opløsning eller oral opløsning
English: • Week three: 20 mg/L in the overnight dialysis bag.
Danish: • Uge 3: 20 mg/l i dialyseposen om natten
English: For Targocid, powder for solution for injection/infusion or oral solution - 1 powder vial - 5x1 powder vials - 10x1 powder vials - 25x1 powder vials
Danish: For Targocid, pulver til injektions-/infusionsvæske, opløsning eller oral opløsning - 1 hætteglas med pulver - 5x1 hætteglas med pulver - 10x1 hætteglas med pulver - 25x1 hætteglas med pulver
English: • 5% dextrose injection
Danish: • 5 % dextroseinjektion
English: Intramuscular, intravenous or oral uses
Danish: Intramuskulær, intravenøs eller oral brug
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON FOR 100 mg, 200 mg and 400 mg / powder and solvent for solution for injection/infusion or oral solution
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON TIL 100 mg, 200 mg og 400 mg/pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning
English: Shelf life of reconstituted solution:
Danish: Holdbarhed for rekonstitueret opløsning:
English: - Complicated skin and soft tissue infections
Danish: Komplicerede infektioner i hud og bløddele
English: Each vial contains 100 mg teicoplanin equivalent to not less than 100,000 IU After reconstitution, the solutions will contain 100 mg teicoplanin in 1.5 mL
Danish: Hvert hætteglas indeholder 100 mg teicoplanin svarende til mindst 100.000 IU Efter rekonstitution indeholder opløsningen 100 mg teicoplanin i 1,5 ml
English: • 10% dextrose injection
Danish: • 10 % dextroseinjektion
English: Loading dose regimen
Danish: Startdosisregime
English: Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder [See Annex I - To be completed nationally]
Danish: Indehaver af markedsføringstilladelsen og fremstiller Indehaver af markedsføringstilladelsen [Se bilag I - Udfyldes nationalt]
English: For intramuscular, intravenous or oral uses
Danish: Til intramuskulær, intravenøs eller oral brug
English: • Starting dose (for the first three to five doses): 800 mg (this equates to 12 mg for every kilogram of body weight), given every 12 hours, by injection into a vein or muscle
Danish: • Startdosis (de første tre til fem doser): 800 mg (dette svarer til 12 mg per kilo legemsvægt) givet hver 12. time ved injektion i en vene (blodåre) eller muskel
English: If you have more Targocid than you should
Danish: Hvis du har fået for meget Targocid
English: Tell your doctor if you are breast-feeding, before being given this medicine.
Danish: Hvis du ammer, skal du fortælle det til lægen, før du får dette lægemiddel.
English: After an intravenous loading dose of 12 mg/kg administered every 12 hours for 3 administrations, mean values of Cmax and Ctrough are estimated to be around 100 mg/L and 20 mg/L, respectively.
Danish: Efter en intravenøs startdosis på 12 mg/kg hver 12. time givet 3 gange estimeres de gennemsnitlige værdier for Cmax og Cmin til hhv. omkring 100 mg/l og 20 mg/l.
English: 25 powder vials
Danish: 25 hætteglas med pulver
English: Staphylococcus haemolyticus
Danish: Staphylococcus haemolyticus Staphylococcus hominis
English: • Maintenance dose: 8 mg for every kilogram of body weight, given once a day, as an infusion through a drip into a vein.
Danish: • Vedligeholdelsesdosis: 8 mg per kilo legemsvægt, som en infusion gennem et drop i en vene
English: For Targocid, powder and solvent for solution for injection/ infusion or oral solution What Targocid contains
Danish: For Targocid, pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid indeholder:
English: Coagulase-negative staphylococci a
Danish: Koagulase-negative stafylokokker a
English: Only the infusion method should be used in neonates.
Danish: Må kun administreres som infusion til nyfødte.
English: (e.g. progressive skin rash often with blisters or mucosal lesions) are present teicoplanin treatment should be discontinued immediately.
Danish: Hvis der opstår symptomer eller tegn på SJS eller TEN (f.eks. progressive hududslæt ofte med vabler eller slimhindelæsioner), skal teicoplanin straks seponeres.
English: Each vial contains 200 mg teicoplanin equivalent to not less than 200,000 IU After reconstitution, the solutions will contain 200 mg teicoplanin in 3.0 mL
Danish: Hvert hætteglas indeholder 200 mg teicoplanin svarende til mindst 200.000 IU Efter rekonstitution indeholder opløsningen 200 mg teicoplanin i 3 ml
English: For Targocid, powder for solution for injection/infusion or oral solution What Targocid contains
Danish: For Targocid, pulver til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid indeholder:
English: One single dose of 6-10 mg/kg body weight administered intravenously once a day.
Danish: 6-10 mg/kg legemsvægt indgivet intravenøst én gang dagligt.
English: • Pain
Danish: • Smerte
English: • Maintenance dose: 400 mg (this equates to 6 mg for every kilogram of body weight), given once a day, by injection into a vein or muscle
Danish: • Vedligeholdelsesdosis: 400 mg (dette svarer til 6 mg per kilo legemsvægt) givet én gang dagligt ved injektion i en vene (blodåre) eller muskel
English: For this, the solution is taken by mouth.
Danish: Til behandling af disse infektioner indtages opløsningen gennem munden.
English: It is unlikely that they will not give you the medicine as prescribed.
Danish: Det er usandsynligt, at de ikke giver dig medicinen som foreskrevet.
English: Pain, pyrexia
Danish: Smerte pyreksi
English: • bone and joint infections,
Danish: • infektioner i knogle og led,
English: Deafness, hearing loss (see section tinnitus, vestibular disorder
Danish: 4.4), tinnitus, vestibulær lidelse
English: • For endocarditis and other severe infections, teicoplanin trough levels of 15-30 mg/L when measured by HPLC, or 30-40 mg/L when measured by FPIA method.
Danish: 15-30 mg/l ved HPLC eller 30-40 mg/l ved FPIA.
English: • Maintenance dose: 6 to 10 mg for every kilogram of body weight, given once a day, by injection into a vein.
Danish: • Vedligeholdelsesdosis: 6-10 mg per kilo legemsvægt givet én gang dagligt ved injektion i en vene (blodåre).
English: Dizziness, headache
Danish: • Udslæt, hudrødme, kløe
English: Targocid and associated names (see Annex I) 100 mg powder and solvent for solution for injection/infusion or oral solution Targocid and associated names (see Annex I) 200 mg powder and solvent for solution for injection/infusion or oral solution Targocid and associated names (see Annex I) 400 mg powder and solvent for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 100 mg pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid og relaterede navne (Se bilag I) 200 mg pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid og relaterede navne (Se bilag I) 400 mg pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning
English: • cisplatin - a medicine that treats malignant tumors which may cause hearing problems and/or kidney problems
Danish: • Cisplatin - et lægemiddel til behandling af kræft; kan forårsage problemer med hørelsen og/eller nyreproblemer
English: • In severe renal insufficiency (creatinine clearance less than 30 mL/min) and in haemodialysed patients: dose should be one-third the usual dose, either by administering the initial unit dose every third day or by administering one-third of this dose once a day.
Danish: dosis skal være en tredjedel af den normale dosis, enten ved at administrere initialdosis hver tredje dag eller ved at administrere en tredjedel af denne dosis én gang dagligt.
English: 5 powder vials
Danish: 5 hætteglas med pulver
English: One single dose of 8 mg/kg body weight administered intravenously by infusion once a day.
Danish: 8 mg/kg legemsvægt indgivet intravenøst én gang dagligt.
English: PHARMACEUTICAL FORM AND CONTENTS Powder and solvent for solution for injection/infusion or oral solution 1 powder vial and 1 solvent ampoule 5 powder vials and 5 solvent ampoules 10 powder vials and 10 solvent ampoules 25 powder vials and 25 solvent ampoules
Danish: 1 hætteglas med pulver samt 1 ampul med solvens 5 hætteglas med pulver samt 5 ampuller med solvens 10 hætteglas med pulver samt 10 ampuller med solvens 25 hætteglas med pulver samt 25 ampuller med solvens
English: Powder for solution for injection/infusion or oral solution: spongy ivory coloured homogeneous mass Solvent: clear, colourless liquid.
Danish: Targocid er et pulver til injektions-/infusionsvæske, opløsning eller oral opløsning Pulveret er en svampet, elfenbensfarvet homogen masse.
English: • Maintenance dose: 800 mg (this equates to 12 mg for every kilogram of body weight), given once a day hours, by injection into a vein or muscle
Danish: • Vedligeholdelsesdosis: 800 mg (dette svarer til 12 mg per kilo legemsvægt) givet én gang dagligt ved injektion i en vene (blodåre) eller muskel
English: Targocid and associated names (see Annex I) 100 mg powder for injection/infusion or oral solution Targocid and associated names (see Annex I) 200 mg powder for injection/infusion or oral solution Targocid and associated names (see Annex I) 400 mg powder for injection/infusion or oral solution [See Annex I - To be completed nationally]
Danish: Targocid og relaterede navne (Se bilag I) 100 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid og relaterede navne (Se bilag I) 200 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning Targocid og relaterede navne (Se bilag I) 400 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning [Se bilag I - Udfyldes nationalt]
English: 5% dextrose injection
Danish: 5 % glucose-injektionsvæske
English: 10% dextrose injection
Danish: 10 % glucose-injektionsvæske
English: Targocid and associated names (see Annex I) 400 mg powder for solution for injection/infusion or oral solution [See Annex I - To be completed nationally]
Danish: Targocid og relaterede navne (Se bilag I) 400 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning [Se bilag I - Udfyldes nationalt]
English: What Targocid is and what it is used for 2.
Danish: Virkning og anvendelse 2.
English: 10 powder vials
Danish: 10 hætteglas med pulver
English: <Detailed information on this medicinal product is available on the website of {name of MS/Agency}>
Danish: <Yderligere information om {X} findes på Sundhedsstyrelsens hjemmeside www.laegemiddelstyrelsen.dk.>
English: Powder and solvent for solution for injection/infusion or oral solution Powder for solution for injection/infusion or oral solution
Danish: Pulver og solvens til injektions-/infusionsvæske, opløsning eller oral opløsning
English: Targocid and associated names (see Annex I) 400 mg powder and solvent for solution for injection/infusion or oral solution [See Annex I - To be completed nationally]
Danish: Targocid og relaterede navne (Se bilag I) 400 mg pulver og solvens til injektios-n/infusionsvæske, opløsning eller oral opløsning [Se bilag I - Udfyldes nationalt]
English: Seizures
Danish: PRODUKTRESUME
English: Streptococci in the viridans group a b Anaerobic Gram-positive bacteria Clostridium difficile a
Danish: (Gruppe C&G streptokokker) Streptococcus pneumoniae Streptococcus pyogenes Streptokokker i viridansgruppe a b
English: • Starting dose (for the first three doses): 10 mg for every kilogram of body weight, given every
Danish: • Startdosis (de første tre doser): 400 mg (dette svarer til 6 mg per kilo legemsvægt) givet hver 12.
English: • in a Type I, colourless glass vial of useful volume of 8 mL for 100 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium red overseal.
Danish: • Type I, farveløst hætteglas med nyttevolumen på 8 ml til 100 mg lukket med brombutylgummiprop og rødt flip-off plastlåg.
English: Type I, colourless glass vial of useful volume of 8 mL for 100 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium red overseal.
Danish: Type I, farveløst hætteglas med nyttevolumen på 8 ml til 100 mg, lukket med brombutylgummiprop og rødt flip-off plastlåg.
English: Type I, colourless glass vial of useful volume of 22 mL for 400 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium green overseal.
Danish: Type I, farveløst hætteglas med nyttevolumen på 22 ml for 400 mg, lukket med brombutylgummiprop og grønt flip-off plastlåg.
English: Viridans group streptococci b
Danish: Streptokokker, Viridansgruppen b
English: Other side effects Talk to your doctor, pharmacist or nurse if you get any of these:
Danish: Tal med din læge, apotekspersonalet eller sundhedspersonalet, hvis du får nogen af nedenstående bivirkninger:
English: 1 powder vial
Danish: − 1 hætteglas med pulver
English: • in a Type I, colourless glass vial of useful volume of 10 mL for 200 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium yellow overseal.
Danish: • Type I, farveløst hætteglas med nyttevolumen på 10 ml til 200 mg lukket med brombutylgummiprop og gult flip-off plastlåg.
English: • in a Type I, colourless glass vial of useful volume of 22 mL for 400 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium green overseal.
Danish: • Type I, farveløst hætteglas med nyttevolumen på 22 ml til 400 mg lukket med brombutylgummiprop og grønt flip-off plastlåg.
English: Type I, colourless glass vial of useful volume of 10 mL for 200 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium yellow overseal.
Danish: Type I, farveløst hætteglas med nyttevolumen på 10 ml til 200 mg, lukket med brombutylgummiprop og gult flip-off plastlåg.
English: 1 powder vial with 1 solvent ampoule 5x1 powder vials with 5x1 solvent ampoules 10x1 powder vials with 10x1 solvent ampoules 25x1 powder vials with 25x1 solvent ampoules.
Danish: − 25x1 hætteglas med pulver samt 25x1 ampuller med solvens
English: When administered by oral route teicoplanin is not absorbed from the gastrointestinal tract.
Danish: Teicoplanin absorberes ikke fra mave-tarm-kanalen efter oral administration.
English: One single dose of 10 mg/kg body weight administered intravenously every 12 hours, repeated 3 times.
Danish: 3 doser indgivet intravenøst som 10 mg/kg legemsvægt hver 12. time.
English: - Bone and joint infections
Danish: Infektioner i knogle og led
English: Targocid and associated names (see Annex I) 200 mg powder and solvent for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 200 mg pulver og solvens til injektions-/infusionsvæske, ipløsning eller oral opløsning
English: • Starting dose (for the first three doses): 400 mg (this equates to 6 mg for every kilogram of body weight), given every 12 hours, by injection into a vein or muscle
Danish: • Startdosis (de første tre doser): 10 mg per kilo legemsvægt givet hver 12. time ved injektion i en vene (blodåre).
English: Targocid and associated names (see Annex I) 400 mg powder for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 400 mg pulver til injektion-/infusionsvæske, opløsning eller oral opløsning
English: Targocid and associated names (see Annex I) 400 mg powder and solvent for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 400 mg pulver og solvens til injektion-/infusionsvæske, opløsning eller oral opløsning
English: QUALITATIVE AND QUANTITATIVE COMPOSITION
Danish: LÆGEMIDDELFORM OG INDHOLDSMÆNGDE (PAKNINGSSTØRRELSE)
English: Targocid and associated names (see Annex I) 100 mg powder and solvent for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 100 mg pulver og solvens til injektions/infusionvæske, opløsning eller oral opløsning
English: Targocid and associated names (see Annex I) 100 mg powder for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 100 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning
English: Targocid and associated names (see Annex I) 200 mg powder for solution for injection/infusion or oral solution
Danish: Targocid og relaterede navne (Se bilag I) 200 mg pulver til injektions-/infusionsvæske, opløsning eller oral opløsning
English: Each vial contains 400 mg teicoplanin equivalent to not less than 400,000 IU.
Danish: Hvert hætteglas indeholder 400 mg teicoplanin svarende til mindst 400.000 IU Efter rekonstitution indeholder opløsningen 400 mg teicoplanin i 3 ml.
English: 12 hours, by injection into a vein.
Danish: time ved injektion i en vene (blodåre) eller muskel
English: • decrease in platelet count.
Danish: • nedsat antal blodplader.
English: 1 pre-filled pen
Danish: 1 fyldt pen
English: 6 (3 x 2) pre-filled pens (multipack)
Danish: 6 (3x2) fyldte penne (multipakning)
English: 1 cartridge + 1 automated minidoser
Danish: 1 cylinderampul + 1 automatisk minidoseringsapp arat
English: 3 (3 x 1) cartridges + 3 (3 x 1) automated minidosers (multipack)
Danish: 3 (3x1) cylinderampuller + 3 (3x1) automatiske minidoseringsapp arater (multipakning)
English: Pre-filled syringe (glass)
Danish: Fyldt injektionssprøjte (glas)
English: 1 pre-filled syringe
Danish: 1 fyldt injektionssprøjte
English: (Invented) name
Danish: MF (EU)-nummer (Særnavn) Navn
English: *** International units.
Danish: *** Internationale enheder.
English: Such reactions may evolve to a more severe condition which may be life-threatening.
Danish: Sådanne reaktioner kan udvikle sig til en mere alvorlig tilstand, som kan være livstruende.
English: ATC vet code: QI07AJ.
Danish: ATCvet-kode: QI07AJ.
English: Suspension (inactivated):
Danish: Suspension (inaktiveret):
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 31/07/2014.
Danish: DATO FOR FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN Dato for første markedsføringstilladelse: 31/07/2014.
English: Store and transport refrigerated (2°C-8°C).
Danish: Opbevares og transporteres nedkølet (2 °C - 8 °C).
English: MARKETING AUTHORISATION NUMBER(S) EU/2/14/173/001
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/14/173/001
English: Active immunisation of dogs from 8-9 weeks of age:
Danish: Til aktiv immunisering af hunde fra 8-9-ugers alderen:
English: The second dose should not be given before 12 weeks of age.
Danish: Den anden dosis bør ikke gives før 12-ugers alderen.
English: Antibody titres drop over the course of the 3-year duration of immunity, although dogs are protected when challenged.
Danish: Antistoftitere falder i løbet af den 3-års varighed af immunitet, selv om hunde er beskyttet.
English: Subcutaneous use.
Danish: Anvendes subkutant.
English: In case of need, dogs younger than 8 weeks can be vaccinated as safety of this product has been demonstrated in 6-week old dogs.
Danish: Ved behov kan hunde under 8-uger vaccineres, da produktets sikkerhed er påvist hos hunde i 6-ugers alderen.
English: However, due to the low pathogenicity of the strain, it is not necessary to keep vaccinated dogs separated from non-vaccinated dogs.
Danish: På grund af disse stammers lave patogenitet er det ikke nødvendigt at holde vaccinerede hunde adskilt fra ikke-vaccinerede hunde.
English: Do not use in animals that are showing signs of rabies or that are suspected of being infected with rabies virus.
Danish: Må ikke anvendes til dyr, der viser symptomer på rabies, eller som formodes at være inficeret med rabiesvirus.
English: The live attenuated virus vaccine strain CPiV may be shed by vaccinated animals following vaccination.
Danish: Den levende, svækkede virusvaccinestamme CPiV kan spredes af vaccinerede dyr efter vaccinationen.
English: Pharmacotherapeutic group: Immunologicals for canidae, live and inactivated viral and inactivated bacterial vaccines.
Danish: Farmakoterapeutisk gruppe: Immunologiske midler til canidae, levende og inaktiverede virus- og inaktiverede bakterievacciner.
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Danish: En eventuel beslutning om at anvende vaccinen umiddelbart før eller efter brug af et andet veterinærlægemiddel til dyr skal derfor tages med udgangspunkt i det enkelte tilfælde.
English: In case of travelling to risk areas or outside the EU, veterinary surgeons may wish to give additional rabies vaccinations after 12 weeks of age to ensure that the vaccinated dogs have an antibody titre of ≥ 0.5 IU/ml, which is generally regarded as sufficiently protective and that they meet the travel test requirements (antibody titres ≥ 0.5 IU/ml).
Danish: I tilfælde af rejser til risikoområder eller ved rejser uden for EU, kan dyrlægen give en ekstra rabiesvaccination efter 12-ugers alderen for at sikre, at de vaccinerede hunde har et antistoftiter på ≥ 0,5 IE/ml som generelt anses for tilstrækkelig beskyttelse, og at det opfylder testkrav for rejser (antistoftiter på ≥ 0,5 IE/ml).
English: * Tissue culture infectious dose 50 %.
Danish: * Vævskulturinficerende dosis - 50 % (tissue culture infectious dose 50 %).
English: However, in field studies 10% of sero-negative dogs did not show seroconversion (> 0.1 IU/ml) 3-4 weeks after single primary vaccination against rabies.
Danish: I feltstudier viste 10% af seronegative hunde dog ikke serokonvertion (>0,1 IE/ml) 3-4 uger efter en enkelt basisvaccination mod rabies.
English: Rabies virus
Danish: Rabiesvirus
English: Re-vaccination scheme:
Danish: Revaccinationsprogram:
English: − to prevent mortality, clinical signs and infection caused by rabies virus.
Danish: − for at forebygge mortalitet, kliniske symptomer samt infektion forårsaget af rabiesvirus.